SPECTROPHOTOMETRIC DETERMINATION OF ATORVASTATINE CALCIUM

Atorvastatin Calcium reduces the level of cholesterol and lipoproteins in blood plasma, inhibits cholesterol synthesis in liver, increasing the number of low-density lipoproteins. It also reduces cholesterol in patients with homozygous familial hypercholesterolemia, which is usually resistant to lip...

Full description

Bibliographic Details
Main Authors: O. Yu. Myronova, S. O. Vasjuk
Format: Article
Language:English
Published: Zaporozhye State Medical University 2015-04-01
Series:Aktualʹnì Pitannâ Farmacevtičnoï ì Medičnoï Nauki ta Praktiki
Subjects:
Online Access:http://pharmed.zsmu.edu.ua/article/view/41370/37804
_version_ 1818473904364060672
author O. Yu. Myronova
S. O. Vasjuk
author_facet O. Yu. Myronova
S. O. Vasjuk
author_sort O. Yu. Myronova
collection DOAJ
description Atorvastatin Calcium reduces the level of cholesterol and lipoproteins in blood plasma, inhibits cholesterol synthesis in liver, increasing the number of low-density lipoproteins. It also reduces cholesterol in patients with homozygous familial hypercholesterolemia, which is usually resistant to lipid-lowering therapy. In today's world physical and chemical methods of analysis,including absorption spectrophotometry in the visible spectrum, which is characterized by ease of performance, availability, accuracy and selectivity,playsleadership role in quality assurance of medicines, The aim of research was the development of highly sensitive, simple and valid spectrophotometric methods of atorvastatin calcium tablets determination based on reaction with bromocresol purple (BCP). To achieve this goal the following objectives have been set: determine the optimal conditions for the photometric response of atorvastatin calcium BCP and calculate analytical performance sensitivity reactions; install coefficients stoichiometric ratio "atorvastatin- BCP"; develop techniques for the quantitative determination of atorvastatin calcium tablets; conduct the validation of the developed techniques. When choosing solvent solubility of atorvastatin calcium and BCP, and maximum optical density obtained solutionwere taken into account. Experimentally, it was found that atorvastatin calcium interacts with BCP in acetone medium to form a colored product with a maximum at 399 nm in absorbance. The value of molar absorbance coefficient is 3.8*103, which indicates high sensitivity of reactions. To check the accuracy of the proposed methods,they were validated by key characteristics, namely, linearity, precision, accuracy and robustness. The results processed by least squares methods show linearity over the entire range of its application. Precision was determined at the level of convergence. Accuracy was established by additives method. Evaluation of robustness was conducted by identifying factors that affect the value of the optical density - namely, the number of added reagents. Conclusions: 1. It has been established that atorvastatin calcium interacts with BCP at room temperature in acetone medium. The investigated reaction is high: the molar absorption coefficient is3.8*103. 2. It has been found that atorvastatin calcium and BCP react in the ratio 1: 1, by the molar ratiomethod and by the continuous changes. 3 The method of spectrophotometric assay of atorvastatin calcium tablets from different manufacturers has been developed. 4 The developed method has been proved in the following validation characteristics as linearity, precision, accuracy and robustness.
first_indexed 2024-04-14T04:29:02Z
format Article
id doaj.art-fa6d7579214249b8b5e52cf4b858217b
institution Directory Open Access Journal
issn 2306-8094
2409-2932
language English
last_indexed 2024-04-14T04:29:02Z
publishDate 2015-04-01
publisher Zaporozhye State Medical University
record_format Article
series Aktualʹnì Pitannâ Farmacevtičnoï ì Medičnoï Nauki ta Praktiki
spelling doaj.art-fa6d7579214249b8b5e52cf4b858217b2022-12-22T02:12:09ZengZaporozhye State Medical UniversityAktualʹnì Pitannâ Farmacevtičnoï ì Medičnoï Nauki ta Praktiki2306-80942409-29322015-04-011323510.14739/2409-2932.2015.1.41370SPECTROPHOTOMETRIC DETERMINATION OF ATORVASTATINE CALCIUMO. Yu. Myronova S. O. VasjukAtorvastatin Calcium reduces the level of cholesterol and lipoproteins in blood plasma, inhibits cholesterol synthesis in liver, increasing the number of low-density lipoproteins. It also reduces cholesterol in patients with homozygous familial hypercholesterolemia, which is usually resistant to lipid-lowering therapy. In today's world physical and chemical methods of analysis,including absorption spectrophotometry in the visible spectrum, which is characterized by ease of performance, availability, accuracy and selectivity,playsleadership role in quality assurance of medicines, The aim of research was the development of highly sensitive, simple and valid spectrophotometric methods of atorvastatin calcium tablets determination based on reaction with bromocresol purple (BCP). To achieve this goal the following objectives have been set: determine the optimal conditions for the photometric response of atorvastatin calcium BCP and calculate analytical performance sensitivity reactions; install coefficients stoichiometric ratio "atorvastatin- BCP"; develop techniques for the quantitative determination of atorvastatin calcium tablets; conduct the validation of the developed techniques. When choosing solvent solubility of atorvastatin calcium and BCP, and maximum optical density obtained solutionwere taken into account. Experimentally, it was found that atorvastatin calcium interacts with BCP in acetone medium to form a colored product with a maximum at 399 nm in absorbance. The value of molar absorbance coefficient is 3.8*103, which indicates high sensitivity of reactions. To check the accuracy of the proposed methods,they were validated by key characteristics, namely, linearity, precision, accuracy and robustness. The results processed by least squares methods show linearity over the entire range of its application. Precision was determined at the level of convergence. Accuracy was established by additives method. Evaluation of robustness was conducted by identifying factors that affect the value of the optical density - namely, the number of added reagents. Conclusions: 1. It has been established that atorvastatin calcium interacts with BCP at room temperature in acetone medium. The investigated reaction is high: the molar absorption coefficient is3.8*103. 2. It has been found that atorvastatin calcium and BCP react in the ratio 1: 1, by the molar ratiomethod and by the continuous changes. 3 The method of spectrophotometric assay of atorvastatin calcium tablets from different manufacturers has been developed. 4 The developed method has been proved in the following validation characteristics as linearity, precision, accuracy and robustness.http://pharmed.zsmu.edu.ua/article/view/41370/37804AnalysisSpectrophotometryCholesterolBromcresol Purple
spellingShingle O. Yu. Myronova
S. O. Vasjuk
SPECTROPHOTOMETRIC DETERMINATION OF ATORVASTATINE CALCIUM
Aktualʹnì Pitannâ Farmacevtičnoï ì Medičnoï Nauki ta Praktiki
Analysis
Spectrophotometry
Cholesterol
Bromcresol Purple
title SPECTROPHOTOMETRIC DETERMINATION OF ATORVASTATINE CALCIUM
title_full SPECTROPHOTOMETRIC DETERMINATION OF ATORVASTATINE CALCIUM
title_fullStr SPECTROPHOTOMETRIC DETERMINATION OF ATORVASTATINE CALCIUM
title_full_unstemmed SPECTROPHOTOMETRIC DETERMINATION OF ATORVASTATINE CALCIUM
title_short SPECTROPHOTOMETRIC DETERMINATION OF ATORVASTATINE CALCIUM
title_sort spectrophotometric determination of atorvastatine calcium
topic Analysis
Spectrophotometry
Cholesterol
Bromcresol Purple
url http://pharmed.zsmu.edu.ua/article/view/41370/37804
work_keys_str_mv AT oyumyronova spectrophotometricdeterminationofatorvastatinecalcium
AT sovasjuk spectrophotometricdeterminationofatorvastatinecalcium